We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
Wi-Fi Securities Limited is a cyber security company that aims to revolutionise the security of public access Wi-Fi. To realise this vision, the company is developing a unique patent-protected system called SpriteGuard™ which will protect you and your data from hackers by stopping you connecting to fake hotspots. The system is targeted towards the $550 bn worldwide hospitality industry and has the ability to expand to other large global markets like city-wide free Wi-Fi, airports and coffee shops. Moreover, Wi-Fi Securities Limited has a highly experienced Wi-Fi Securities management board that has a track record of delivering multi-million-pound projects from concept to successful commercial deployment.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Extended investment: £1,014,708
Medic Bleep is a simple, secure and innovative patient-focused solution to communication challenges that healthcare professionals and the wider team in the UK National Health Service (NHS) face while going about their everyday work. It is saving each nurse & each junior doctor an estimated 48 minutes per shift. This coincides with the UK's Department of Health calling for a ban on pagers. If implemented across the NHS, it could free up the time to care for an estimated 11,000 nurses. To ensure data privacy and safety, the company allows communication to occur via the app. As a result of these safeguards and its user-friendly portal, the company's app has been downloaded 16,000 times by UK doctors and nurses. With the funds raised, the company will aim to solve looming technology gaps for over 30% of the NHS in the next 3 years and expand globally.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £814,600
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £103,672
The Noo aims to redefine the delivery space by facilitating the delivery of anything, anywhere, anytime from a single application. It argues that between February-April 2020, online food delivery weekly sales skyrocketed by 840% amidst a boom in e-commerce sales. The Noo points out that with every innovation in the name of convenience, people seem to expect more. It intends to deliver just that through its community platform allowing anyone to request anything at a price set by the requestor and finally, facilitate earning by simply owning a smartphone. The company also aspires to create a space where the local high street can compete with today's delivery giants. It will use the investment to enhance and launch its app, fund marketing campaigns, hire key personnel, and make The Noo visible across more cities.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £149,388
TellJO is a company that comes with a mission to help 25M people of the UK who are susceptible to vulnerability. The company's TrustTech platform 'TellJO digital' is an intermediary between businesses and their vulnerable customers. TellJO has been utilised by 3 companies, and it is supported by Bethnal Green Ventures. The company is looking forward to developing "Team TellJO" that will help it achieve sustainable but rapid growth. With the proceeds, the company is looking forward to scaling its 1st to the market solution and develop the TellJO team.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £82,290
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £200,000
paus is an on-demand streaming service. It offers specialist, hand-picked independent films to today's streamers who wish to avail a niche streaming service in 2020. The company aims to propel curated independent cinema into the $161 billion global streaming market by replacing conventional subscription and ad-based models with a peer-to-peer digital tipping model. paus is working with globally recognised film institutions to procure curated content. Over 1,900 people have signed up for early access to its iOS app. The company is currently rolling out a beta iOS version in the UK and US. It will use the investment to move into streaming theatre and web-series on its portal.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £352,724
Rnwl is aiming to be the first ever over-the-top insurance platform. The company asserts that conventional insurance companies rely on a lead generation business model that is archaic and inefficient. These result in a customer's insurance options becoming an expensive and time-consuming affair. Rnwl is endeavouring to simplify this. Users can enter their credentials and requirements on the Rnwl website. The company will analyse the market and suggest the best deals for the user. Rnwl has been accepted into the Financial Conduct Authority (FCA's) Innovation Hub. It will use 74% of the investment in human resource, 14% in marketing, and 12% as operational costs.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £450,366
ClickMechanic offers car repairs, servicing, Ministry of Transport tests (MOTt), diagnostics and pre-purchase inspections through its nationwide marketplace of vetted mechanics. The company cites research group Mintel's data stating that 50% of drivers got ripped off by car service centres. ClickMechanic wants to change this and become a leading contender in the £23 billion UK automotive servicing industry. The company takes a 20% commission on every completed booking and has secured a Net Promoter Score (NPS) of 85+ for its services. Their exit strategy is via an Initial Public Offering (IPO) or trade sale.

Pitch Rated

86%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £100,000
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £211,595
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph